Posts Tagged ‘GLP-1 agonists’
January 19, 2025 — Narratives in health reporting tend to cluster. This is how we get diet fads. It’s also why stories about how bad BMI is have gotten enough traction to drive people to extreme views about it. Lately, we’ve noticed a new cluster forming. Let’s call it the premature death notices for diet and exercise. In Vox […]
January 10, 2025 — Let’s talk selfies. For me, they were my reality check. Full-body shots? Forget it. Every milestone photo with my family got run through every beautification filter the App Store could throw at me, but nothing could match the image I wanted to see staring back. That’s when I knew – it was time for a […]
January 7, 2025 — It used to be that this was the time of year when popular culture turned its attention to weight loss season. The release of U.S. News rankings of “Best Diets” commanded media attention. Weight loss tips were everywhere. But no more is this true. No, idle talk about weight loss has not disappeared. But it […]
January 4, 2025 — The ongoing debate about the clinical definition of obesity is soon to get more intense. But already, it tells us pretty clearly that obesity is defined by more than excess weight. New research in Nature Medicine comes at this subject from an entirely different direction. Using proteomics, Lasse Maretty and colleagues find that the effects […]
January 1, 2025 — Thankfully, 2024 is behind us now and we have a blank slate for a whole new year ahead of us. But what can we expect? Well, proverbial (probably Danish) wisdom tells us “prediction is difficult, especially if it’s about the future.” Nonetheless, here are our top five predictions about what we will see in 2025 […]
December 19, 2024 — This was a pleasant surprise. For years, the World Health Association avoided the idea that obesity is an actual chronic disease. Today we have evidence for a big shift in thinking. Three senior officials from WHO published a viewpoint in JAMA yesterday to clearly say not only that obesity is a chronic disease, but also […]
December 17, 2024 — One of the harms that weight stigma causes is the avoidance of medical care. But an unexpected side effect of GLP-1 therapy in persons with overweight or obesity may be increased engagement with healthcare. This insight comes from a new analysis of electronic health records for 711,783 persons. As the use of these medicines for […]
December 14, 2024 — Let’s be quite clear. This is encouraging news, but it is nothing more than a glimmer of a possibility that there is a drop in U.S. obesity prevalence showing up in 2023. The data come from electronic health records. From a sample of 16,743,822 U.S. adults, Benjamin Rader, Rebecca Hazan, and John Brownstein analyzed 47,939,382 […]
December 4, 2024 — Why can’t they just go away? When compounded GLP-1 medicines started showing up two years ago, they seemed like a temporary distraction. In The New Yorker, Jia Tolentino described a dubious concoction of semaglutide she obtained from a compounding pharmacy for herself to mix and inject. “No thanks,” we wrote, hoping this sketchy business would […]
November 27, 2024 — Yesterday, Amgen released topline data on their remarkable monthly obesity medicine – MariTide or maridebart cafraglutide. To us, the results are impressive, albeit preliminary. In 52 weeks of study, patients with obesity or overweight lost approximately 20% of their initial body weight and even after a year, they appeared to still be losing weight. For […]